Compare Sprott Uranium Miners ETF (URNM) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sprott Uranium Miners ETF vs GeneDx Holdings Corp — how do they compare? Sprott Uranium Miners ETF trades at $46.5 (market cap $1.87B), while GeneDx Holdings Corp trades at $67.33 (market cap $2.02B). The key difference: Sprott Uranium Miners ETF and GeneDx Holdings Corp are close in size by market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Sprott Uranium Miners ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Sprott Uranium Miners ETF for 61 Days and GeneDx Holdings Corp for 19 Days on average.
| URNM | WGS | |
|---|---|---|
Market Cap | $1.87B | $2.02B |
Volume | 1,586,926 | 734,640 |
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $83.99 | $167.51 |
52-Week Low | $46.09 | $34.51 |
Typical Hold Time | 61 Days | 19 Days |
Enterprise Value | — | $2.05B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
URNM trades at $46.50, down 2.86% today amid bearish technical signals with 19 sell indicators versus 4 buy. The ETF faces resistance near $47 while finding support at $45-46 levels. Recent news highlights uranium's long-term growth potential driven by AI energy demand and nuclear expansion, though short-term volatility persists.
The uranium mining ETF benefits from structural supply deficits and government nuclear investments, but faces near-term price pressure. Key risks include commodity price volatility and execution challenges among constituent miners. Analyst sentiment remains mixed with bullish long-term themes offset by technical weakness.
GeneDx (WGS) trades at $67.33, down 1.75% today, with a mixed technical picture showing bearish moving averages but oversold RSI readings. The company reported Q2 2026 revenue of $114.4M, beating expectations with a return to adjusted profitability, though full-year 2026 shows negative net margins. Recent news highlights product launches and positive analyst coverage with 91% buy ratings.
While analyst consensus is strongly bullish with an $81 price target, fundamental risks remain due to negative profitability and high valuation multiples. The stock offers potential upside if operational improvements continue, but investors face execution risk amid ongoing losses and competitive pressures in the genomics space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Sprott Uranium Miners ETF
URNM is a pure-play ETF that invests in the global uranium industry. It provides exposure to companies involved in the mining, exploration, and production of uranium, as well as physical uranium holdings, with top assets like Cameco, Uranium Energy Corp, and the Sprott Physical Uranium Trust.
Read more on URNM →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
